We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-11.87%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$221B
AUM Growth
-$31.8B
Cap. Flow
+$2.77B
Cap. Flow %
1.26%
Top 10 Hldgs %
15.08%
Holding
8,767
New
731
Increased
3,710
Reduced
3,260
Closed
648

Sector Composition

Rank Sector Weight
1 Technology 8.03%
2 Financials 6.64%
3 Healthcare 6.26%
4 Consumer Discretionary 5.11%
5 Industrials 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRX icon
7676
TRX Gold Corp
TRX
$254M
$3K ﹤0.01%
8,989
+708
+9% +$266
UEVM icon
7677
VictoryShares Emerging Markets Value Momentum ETF
UEVM
$252M
$3K ﹤0.01%
71
+13
+22% +$559
VGZ icon
7678
Vista Gold
VGZ
$251M
$3K ﹤0.01%
5,227
-162
-3% -$83
XBIO icon
7679
Xenetic Biosciences
XBIO
$5.82M
$3K ﹤0.01%
+17
New +$5.15K
XTNT icon
7680
Xtant Medical Holdings
XTNT
$60.3M
$3K ﹤0.01%
1,887
+1,159
+159% +$3.74K
ZKIN icon
7681
ZK International Group
ZKIN
$77.4M
$3K ﹤0.01%
260
+223
+603% +$3.45K
CSCI
7682
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$3K ﹤0.01%
10
-127
-93% -$30.4K
ACCS
7683
ACCESS Newswire
ACCS
$25.6M
$3K ﹤0.01%
229
+39
+21% +$497
ENSV
7684
DELISTED
Enservco Corp.
ENSV
$3K ﹤0.01%
637
-331
-34% -$3.07K
GENE
7685
DELISTED
Genetic Technologies Ltd.
GENE
$3K ﹤0.01%
203
+138
+212% +$2.86K
YTEN
7686
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$3K ﹤0.01%
+4
New +$4.88K
SUNW
7687
DELISTED
Sunworks, Inc.
SUNW
$3K ﹤0.01%
+1,711
New +$4.61K
CYTO
7688
DELISTED
Altamira Therapeutics Ltd
CYTO
$3K ﹤0.01%
+1
New +$5.11K
AMRS
7689
DELISTED
Amyris Inc.
AMRS
$3K ﹤0.01%
853
-7,552
-90% -$43.5K
NVNOW
7690
DELISTED
enVVeno Medical Corporation Warrants
NVNOW
$3K ﹤0.01%
6,200
+2,400
+63% +$1.3K
AVYA
7691
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$3K ﹤0.01%
195
-161,241
-100% -$2.74M
AHPI
7692
DELISTED
Allied Healthcare Products
AHPI
$3K ﹤0.01%
1,431
-2,431
-63% -$4.92K
HIL
7693
DELISTED
Hill International, Inc. Common Stock
HIL
$3K ﹤0.01%
+878
New +$2.8K
RADA
7694
DELISTED
Rada Electronic Industries Ltd
RADA
$3K ﹤0.01%
+1,312
New +$3.74K
INFR
7695
DELISTED
Legg Mason ETF Investment Trust Legg Mason Global Infrastructure ETF
INFR
$3K ﹤0.01%
101
SQBG
7696
DELISTED
Sequential Brands Group, Inc.
SQBG
$3K ﹤0.01%
91
+78
+600% +$3.52K
CHEP
7697
DELISTED
AGFiQ U.S. Market Neutral Value Fund
CHEP
$3K ﹤0.01%
140
DJPY
7698
DELISTED
Exchange-Traded Notes linked to the VelocityShares Daily 4X Long USD vs. JPY Index due December 6, 2
DJPY
$3K ﹤0.01%
150
SCON
7699
DELISTED
Superconductor Technologies Inc.
SCON
$3K ﹤0.01%
+271
New +$4.58K
DTYL
7700
DELISTED
iPath US Treasury 10-year Bull ETN
DTYL
$3K ﹤0.01%
75

Similar funds

UBS Group's Q4 2018 Portfolio in Review

As of Q4 2018, UBS Group held 8,767 positions worth $221B, down 13% from $252B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group's Q4 2018 filing shows 731 new, 3,710 increased, 3,260 reduced and 648 closed positions. Its largest new stake was Linde: 4,971,408 shares worth $776M. The largest sale was Energy Transfer Partners, L.P., an estimated $1.06B.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9.3% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2018 buy was Linde: 4,971,408 shares worth $776M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.82B increase.
  • UBS Group's biggest Q4 2018 reduction was Colgate-Palmolive, cutting an estimated $665M.
  • UBS Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.06B.
  • UBS Group's ten largest holdings make up 15% of its $221B portfolio in Q4 2018.
  • UBS Group opened 731 new positions and closed 648 in Q4 2018.
  • UBS Group's portfolio value fell 13% quarter-over-quarter to $221B.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.